The γδ17 T cells subset, capable of producing IL-17, can alter the tumor microenvironment by supporting angiogenesis and the formation of vascular connections that nourish the tumor, a state which is associated with poorer patient outcomes (203, 204). This evidence concerns the gene IL17A and neoplasm.